- Provide statistical strategy and oversight for multiple clinical studies.
- Design studies, author and review protocols and Statistical Analysis Plans.
- Support regulatory submissions, including health authority interactions.
Jobs ranked by similarity.
Kailera develops therapies that give people the power to transform their lives and elevate their overall health. They are rooted in an entrepreneurial spirit and a team-oriented culture, working together to advance novel therapies for obesity and related conditions.
ClinChoice is a global full-service CRO specializing in clinical development and functional solutions for pharmaceutical, biotechnology, medical device, and consumer health companies. They have over 4,000 professionals in more than 20 countries across the Americas, Europe, and Asia-Pacific.
Tarsus is dedicated to attracting and retaining top talent. The company offers comprehensive benefits, bonus, and stock equity to promote work-life balance.
ClinChoice is a global full-service CRO specializing in clinical development and functional solutions for pharmaceutical, biotechnology, medical device, and consumer health companies. They have over 4,000 professionals in more than 20 countries across the Americas, Europe, and Asia-Pacific.
ClinChoice is a global full-service CRO specializing in clinical development and functional solutions for pharmaceutical, biotechnology, medical device, and consumer health companies. They have over 4,000 professionals in more than 20 countries across the Americas, Europe, and Asia-Pacific with a strong focus on quality, professional development, and supportive culture.
Kailera is developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, they are working together to advance novel therapies for obesity and related conditions.
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. They aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions.
Nuvalent is working to create selective medicines designed with the goal to address the needs of patients with cancer using its expertise in chemistry. Nuvalent is an early-stage company bringing together experienced scientists and industry veterans with a proven track record in oncology drug development.